arrow
B

Bengt Glimelius

Uppsala University
H指数:115
被引数:7.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Disease-phase-specific resource utilization and healthcare costs in metastatic colorectal cancer: a subgroup analysis of the finnish RAXO study

转移性结直肠癌各疾病阶段资源利用和医疗成本:芬兰RAXO研究的一个亚组分析

2025-11-010
PRE
KRAS and NRAS mutations in Nordic population-based and real-world metastatic colorectal cancer cohorts
2025-10-210
OAAI
Corrigendum to “Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population”

勘误表:“Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population”

2025-10-100
OAAI
Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

PI3K-altered局部结直肠癌的低剂量阿司匹林治疗

2025-09-189
PRE
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial

RAPIDO试验中,总新辅助治疗后与化放疗后局部晚期直肠癌局部区域复发率的影响因素

BJS
IF8.7
2025-09-020
PRE
Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial

在RAPIDO试验中,与三维适形放射治疗相比,采用调强放射治疗局部晚期直肠癌后的急性期和晚期放射相关毒性。

2025-05-100
PRE
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population

新辅助FOLFOX联合或不联合帕尼单抗治疗KRAS野生型局部晚期结肠癌患者:基于FOxTROT试验嵌入的II期人群,并采用扩展生物标志物面板的研究结果

2025-01-011
PRE
Cost-utility of systemic anticancer therapy (SACT) with or without metastasectomy including local ablative therapy (LAT) for metastatic colorectal cancer (mCRC) patients

系统性抗肿瘤治疗(SACT)联合或未联合转移灶切除术(包括局部消融治疗,LAT)在转移性结直肠癌(mCRC)患者中的成本-效用分析

2024-09-010
PRE
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial

从结直肠癌手术到辅助化疗的时间SCOT随机临床试验的事后分析

2024-08-011
PRE
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

在RAPIDO试验中,高危局部晚期直肠癌的总新辅助治疗或放化疗后病理完全缓解后的肿瘤学结局

2024-06-014
OAAI
identification of spatially enriched cancer cell- and immune cell-regulatory multi-marker-defined prognostic cancer associated fibroblast subsets of human colon cancer
2024-03-220
PRE